EBITDA has been registered at Rs 200.6 crore

Inventurus Knowledge Solutions, a technology-enabled healthcare solutions provider that offers a care enablement platform assisting physician enterprises in the US, Canada and Australia, with a focus on the US markets announced its financial results for the quarter that ended December 31, 2024, demonstrating strong revenue growth and profitability expansion.

“We continue our journey of improving profitability by transforming legacy AQuity’s operating model through technology and global human capital. EBITDA margins have crossed 30 per cent this quarter, a significant improvement from the 24 per cent proforma margin of FY2024. With revenue from our top five customers growing 19 per cent and new client acquisitions ramping up, we are optimistic about sustained growth heading into the final quarter and the next financial year,” Sachin K Gupta, Founder and CEO, IKS Health.

“We are steadily regaining our legacy IKS EBITDA margins. PAT growth has outpaced EBITDA growth due to lower finance costs as we repay our debt. Adjusted PAT, excluding non-cash amortization of acquired intangibles, has improved by 31 per cent. We will maintain our investments in technology and AI to drive superior outcomes and enhance customer satisfaction,” adds Nithya Balasubramanian, Chief Financial Officer, IKS Health.

Key Financial Highlights: Quarter ended December 31, 2024

● Revenue at Rs 657.2 crore (15.9 per cent YoY / + 2.2 per cent QoQ growth)

● EBITDA at Rs 200.6 crore at 30.5 per cent of revenue (24.3 per cent YoY / +5.7 per cent QoQ growth)

● PAT at Rs 129.7 crore at 19.7 per cent of revenue (27.7 per cent YoY / 14.8 per cent QoQ growth)

● Adjusted PAT at Rs 145.5 crore at 22.1 per cent of revenue (30.6 per cent YoY / 12.8 per cent QoQ growth)